MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Integrated Diagnostics expects margin recovery after profits rise 95%

ALN

Integrated Diagnostics PLC on Thursday said profit nearly doubled during 2024, and that it expects to see ‘further recovery in margins’ throughout 2025.

Integrated is a Cairo, Egypt-based provider of clinical pathology and radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia and Sudan.

The company said pretax profit rose 95% to EGP1.44 billion, about £21.3 million, in 2024, up from EGP737.4 million in 2023.

The firm’s revenue also increased by 39% to EGP5.71 billion in 2024, up from EGP4.12 billion in 2023. This was as a result of the company experiencing rising test and patient volumes, performing 39.2 million tests and serving around 9 million patients across its five markets.

According to Integrated, as inflation normalises across its markets, it expects to see recoveries in its margins, building upon cost optimisation and maximising artificial intelligence tools across the business.

Integrated shares rose 7.4% to $0.35 in London on Thursday afternoon.

Copyright 2025 Alliance News Ltd. All Rights Reserved.